A prospective cross sectional study of detection of Clostridium difficile toxin in patients with antibiotic associated diarrhoea
,
Abstract
Background and Objectives: Clostridium difficile infections (CDI) include self-limiting antibiotic associated diarrhoea (AAD), antibiotic-associated colitis, and pseudomembranous colitis. The present study aimed at detecting C. difficile toxin in stool samples of patients with AAD and analyzing the antibiotic use and presence of other risk factors in these patients.
Materials and Methods: In this study, which was conducted on 660 samples, a 2- step strategy was used. In the first step, glutamate dehydrogenase (GDH) was detected in stool samples by enzyme- linked immunofluorescent assay (ELFA). In the second step, GDH positive samples were tested for C. difficile toxin A and B by ELFA. Nucleic acid amplification test (NAAT) was also performed on few samples that were found to be GDH positive and toxin negative or equivocal by ELFA.
Results: Of the 660 samples screened, toxin was detected in 8.8% (58/660) by ELFA and 9.7% (64/660) by NAAT. GDH was detected in 23.8% (157/660) and toxin in 36.9% (58/157) of the GDH positives. Most of the toxin positive patients were on one or more antibiotics prior to developing diarrhoea. The implicated antibiotics were meropenem, amikacin, colistin and cephalosporins. Diabetes, hypertension, use of proton pump inhibitors, previous hospitalization, malignancy and chemotherapy were found to be the risk factors in our study.
Conclusion: Prevalence of GDH was 23.8% (157/660) by ELFA. Toxin prevalence was 9.7% (64/660). Detection rates of C. difficile associated diarrhoea (CDAD) increased with inclusion of NAAT testing by ELFA.
Khan FY, Elzouki AN. Clostridium difficile infection: a review of the literature. Asian Pac J Trop Med 2014; 7S1:S6-S13.
Vaishnavi C. Clostridium difficile infection: clinical spectrum and approach to management. Indian J Gastroenterol 2011; 30: 245-254.
Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infection. Clin Microbiol Rev 2010; 23: 529-549.
Burke KE, Lamont JT. Clostridium difficile Infection: a worldwide disease. Gut Liver 2014; 8: 1-6.
Schwan C, Stecher B, Tzivelekidis T, Van Ham M, Rohde M, Hardt WD, et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog 2009;5(10):e1000626.
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-455.
Fenner L, Widmer AF, Goy G, Rudin S, Frei R. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 2007;46:328-30.
Brown NA, Lebar WD, Young CL, Hankerd RE, Newton DW. Diagnosis of Clostridium difficile infection: comparison of four methods on specimens collected in Cary-Blair transport medium and tcdB PCR on fresh versus frozen samples. Infect Dis Rep 2011; 3(1): e5.
LaSala PR, Svensson AM, Mohammad AA, Perrotta PL. 2012. Comparison of analytical and clinical performance of three methods for detection of Clostridium difficile. Arch Pathol Lab Med 2012; 136:527-531.
Vaishnavi C, Kochhar R, Bhasin DK, Thapa BR, Singh K. Detection of Clostridium difficile toxin by an indigenously developed latex agglutination assay. Trop Gastroenterol 1999; 20:33-35.
Joshy L, Chaudhry R, Dhawan B. Detection and characterization of Clostridium difficile from patients with antibiotic-associated diarrhoea in a tertiary care hospital in North India. J Med Microbiol 2009;58(Pt 12):1657-1659.
Dhawan B, Chaudhry R, Sharma N. Incidence of Clostridium difficile infection: a prospective study in an Indian hospital. J Hosp Infect 1999; 43: 275-280.
Ingle M, Deshmukh A, Desai D, Abraham P, Joshi A, Rodrigues C, et al. Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis. Indian J Gastroenterol 2011; 30: 89-93.
Segar L, Easow JM, Srirangaraj S, Hanifah M, Joseph NM, Seetha KS. Prevalence of Clostridium difficile infection among the patients attending a tertiary care teaching hospital. Indian J Pathol Microbiol 2017;60:221-225.
Ursula C. Patel, Jeffrey T. Wieczorkiewicz, Jerry Tuazon. Evaluation of advanced age as a risk factor for severe Clostridium difficile infection. JCGG 2016; 7:12-16.
Eliakim-Raz N, Fishman G, Yahav D, Goldberg E, Stein GY, Zvi HB, et al. Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case-control study. Eur J Clin Microbiol Infect Dis 2015; 34:1201-1205.
Gopal Rao G, Mahankali Rao CS, Starke I. Clostridium difficile-associated diarrhoea in patients with communityacquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy. J Antimicrob Chemother 2003;51:697-701.
Niyogi SK, Dutta P, Dutta D, Mitra U. Clostridium difficile and its cytotoxin in hospitalized children with acute diarrhea. Indian Pediatr 1991;28:1129-1132.
Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012;67:742-748.
Wieczorkiewicz JT, Lopansri BK, Cheknis A. Fluoroquinolone and macrolide exposure predict Clostridium difficile infection with the highly fluoroquinolone and macrolide-resistant epidemic C. difficile Strain BI/NAP1/027. Antimicrob Agents Chemother 2016; 60: 418-423.
Bartlett JG. How to identify the cause of antibiotic-associated diarrhea. J Crit Illn 1994;9:1063-1067.
Savola KL, Baron EJ, Tompkins LS, Passaro DJ. Fecal leukocyte stain has diagnostic value for outpatients but not inpatients. J Clin Microbiol 2001;39:266-269.
Zar FA, Bakkanagari SR, Moorthi KM. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-307.
| Files | ||
| Issue | Vol 10 No 1 (2018) | |
| Section | Original Article(s) | |
| Keywords | ||
| Clostridium difficile Toxin Antibiotic associated diarrhoea | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
